21st Century Cures Act - Precision Medicine Initiative

Active

Assistance listing
93.368
Agency
Grant awards
13 $450,227,896 in federal obligations

Program facts

Also known as
All of Us Research Program
Assistance types
  • Cooperative Agreement
  • Project Grant
Treasury account
  • 75-2025-0-0-028
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Department of Health and Human Services National Institutes of Health Office of the Director is funding precision medicine research leveraging the All of Us Research Program cohort, with the most recent grant awards made in September 2023 under CFDA 93.368.

Grant activity has accelerated sharply in the past few years, with eight awards made in 2023 alone compared to sporadic funding prior (one award each in 2012, 2016, 2017, and 2019, and two in 2019). The program has obligated $450.2 million in federal dollars across 13 awards since 2012. Recent awards cluster heavily in 2023, with all funding channeled through a single federal agency—the NIH Office of the Director—indicating sustained institutional commitment.

The program funds secondary research analyses on biospecimens, genomic data, and electronic health records from the All of Us cohort to investigate associations between biomarkers, genetic variants, social determinants of health, and chronic disease outcomes across diverse populations. Representative recent awards include genome-wide association studies examining family health history as proxy phenotypes in Alzheimer's disease genetics ($874,688), discovery and analysis of somatic copy-number variants in the All of Us cohort ($645,600), and analyses of allostatic load and chronic disease risk in diverse Asian Americans ($875,516). Two notable large cooperative agreements support biobank operations (Mayo Clinic biospecimen processing and storage, $366.2 million) and participant engagement technology infrastructure (Vibrent Health, $78.2 million). The portfolio is predominantly Project Grants (85 percent), with a smaller share of Cooperative Agreements (15 percent). Individual Project Grant awards typically range from $230 thousand to $1.4 million per award.

A current solicitation (PAR-27-069, due March 1, 2027) invites biomarker analysis projects to access All of Us biospecimens for discovery, validation, novel disease stratification, and multiomics integration in support of precision medicine, with broad applicant eligibility including nonprofits, educational institutions, small businesses, and tribal organizations. Funding decisions prioritize scientific merit, program relevance, and program balance, with approximately ten months to funding decision for grants and cooperative agreements.

Objective and description

Objective

To provide support for initiatives funded under the 21st Century Cures Act, the All of Us Research Program will gather data from one million or more diverse people living in the United States to accelerate research and improve health. By taking into

Description

The All of Us Research Program will gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, environment, and biology, researchers will uncover paths toward delivering precision medicine.

Eligibility

Applicant eligibility

The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that applies and receives an award for support of research by a named principal investigator. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.

Beneficiary eligibility

Any nonprofit or for-profit organization, company, or institution engaged in biomedical research.

Uses of assistance

Other Transactions, Contracts, IAAs, Grants and cooperative agreements may be made to eligible institutions for the support of the All of Us Research Program projects. The awards may be used for personnel, consultant costs, equipment, supplies, travel, patient costs, animals, alterations and renovations, miscellaneous items, and Facilities and Administrative Costs (formerly known as indirect costs).

Use restrictions

Other Transactions, Contracts, IAAs, Grants and cooperative agreements may be made to eligible institutions for the support of the All of Us Research Program projects. The awards may be used for personnel, consultant costs, equipment, supplies, travel, patient costs, animals, alterations and renovations, miscellaneous items, and Facilities and Administrative Costs (formerly known as indirect costs).

Length and time phasing of assistance

Other Transactions, Grants and Cooperative Agreements: Average 3 to 5 years. Renewals may be awarded for additional periods. Method of rewarding/releasing assistance: funding is provided through Monthly Demand Payment System or an Electronic Transfer System

How to apply

Preapplication coordination

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application procedure

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. For Grants and Cooperative Agreements, 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. For Other Transactions, Section 402 (n) of the Public Health Service Act, 42 U.S.C. 282 (n) apply to this program.

Criteria for selecting proposals

For grants and cooperative agreements, funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment. For Other Transactions the Research Opportunity Announcement (ROA) will detail the review process for each initiative.

Award procedure

Grants and cooperative agreements are funded based on scientific merit, program relevance, and program balance and are made annually. The initial grant award provides funds for the first budget period (usually 12 months) and letter Notice of Award indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories and special conditions, if any. Other Transactions are awarded based on the criteria stated within the research opportunity announcement for each initiative.

Time to approval or disapproval

Grants/Cooperative Agreements: Approximately 10 months. Other Transactions: varies

Renewals

Applications submitted for renewal are reviewed and selected for funding on a competitive basis.

Appeals

For grants/cooperative agreements: A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page www.nih.gov/grants/guide/notice-files/not97-232.html . For Other Transactions the Research Opportunity Announcement (ROA) will detail the appeals process for each initiative.

Grant opportunities

Grant awards

Award Recipient Federal obligations Awarded
Characterizing pervasive biases in genome-wide association study using family health history as proxy phenotypes R21AG085162 University Of Wisconsin System $874,688
Discovering and analyzing development and age-associated cnas in the all of US cohort R03AG085705 Mayo Clinic $645,600
Linking social-behavior contextual factors and allostatic load to chronic diseases in diverse asian americans: a… R21MD019145 Temple University-Of The Commonwealth System Of Higher Education $875,516
Identifying genetic and sociodemographic determinants of susceptibility to infectious diseases in diverse population… R21MD019104 Icahn School Of Medicine At Mount Sinai $950,625
Darsaw: developing, assessing, and refining synthetic sampling weights to improve generalizability of the all of US… R21MD019103 Vanderbilt University Medical Center $1,371,931
Examining the associations between women's experiences with gender-based discrimination and their mental and physical… R03MH135379 Marquette University $230,733
Using genomics and extensive phenotyping to dissect the relationships between substance use disorders and chronic pain R03DA059747 The Washington University $450,950
Metabolic syndrome severity in all of US: relationship with social determinants of health and with long-term risk for… R03HL172130 Rector & Visitors Of The University Of Virginia $351,492
HCM strategists proposal for: all of US research program engagement and retention innovators (OT2) - building a… OT2OD028404 HCM Strategists, LLC -$1,513,978
Engaging all of US for effective precision medicine - the university of utah and its community partners will bring a… OT2OD028414 University Of Utah $0

Latest 10 of 13 listed here. See the rest on GovTribe.

Top recipients by federal obligations

Rank Recipient Federal obligations Share
1 Mayo Clinic $366,838,592 81%
2 Vignet Inc. $78,239,640 17%
3 Brigham Young University $1,557,708 <1%
4 Vanderbilt University Medical Center $1,371,931 <1%
5 Icahn School Of Medicine At Mount Sinai $950,625 <1%
6 Temple University-Of The Commonwealth System Of Higher Education $875,516 <1%
7 University Of Wisconsin System $874,688 <1%
8 The Washington University $450,950 <1%
9 Rector & Visitors Of The University Of Virginia $351,492 <1%
10 Marquette University $230,733 <1%

10 of 12 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 -$5,192,285
FY2025 -$6,773
FY2024 $58,521,608
FY2023 $118,836,014
FY2022 $117,509,100
FY2021 -$1,513,978
FY2019 $23,989,999

Quick answers

What is Assistance Listing 93.368?

Assistance Listing 93.368 is 21st Century Cures Act - Precision Medicine Initiative, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for 21st Century Cures Act - Precision Medicine Initiative?

Its CFDA number is 93.368: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.368 awarded?

13 grant awards under 93.368 have obligated $450,227,896 in federal funds to 12 recipients.

Who receives the most funding from 93.368?

The recipients obligated the most under 21st Century Cures Act - Precision Medicine Initiative are Mayo Clinic ($366,838,592), Vignet Inc. ($78,239,640) and Brigham Young University ($1,557,708).

How much did 93.368 obligate in fiscal year 2025?

Grants under 93.368 obligated -$6,773 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.368?

1 listed opportunity under 93.368 is open or forecasted. The latest, Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed), was posted on January 8, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program